Dyne Therapeutics

Dyne is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.

Industries

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Joshua Brumm
President & CEO
Collapse
Wildon Farwell
Chief Medical Officer
Oxana Beskrovnaya
Chief Scientific Officer
Susanna High
Chief Operating Officer
Rick Scalzo
SVP, Head of Finance & Administration
Chris Mix
SVP, Pharmacovigilance
Jonathan McNeill
SVP, Business Development
Francesco Bibbiani
SVP, Head of Development
John Najim
SVP, Chemistry, Manufacturing & Controls
Amy Reilly
SVP, Head of Corporate Communications & Investor Relations
Debra Feldman
VP, Head of Regulatory
Molly White
VP, Global Head of Patient Advocacy & Engagement
Daniel Wilson
VP, Head of Intellectual Property
Kate Mitchell
VP, Head of Human Resources